Welcome to our dedicated page for Under Armour SEC filings (Ticker: UAA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Under Armour, Inc. (UAA) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including current reports on Form 8-K, proxy statements, and other key documents filed with the U.S. Securities and Exchange Commission. Under Armour is a Maryland corporation with Class A and Class C common stock listed on the New York Stock Exchange, and its filings provide detailed insight into operations, governance, capital structure, and material events.
Through its Form 8-K filings, Under Armour reports a range of developments: quarterly financial results, restructuring and transformation initiatives, executive appointments and departures, and significant financing transactions. For example, the company has filed 8-Ks describing its fiscal 2025 restructuring plan and its expansion, including expected restructuring charges and transformation expenses; the private offering and closing of 7.250% Senior Notes due 2030 and the planned use of proceeds to address 3.25% Senior Notes due 2026; and the satisfaction and discharge of those 2026 notes through deposits with the trustee.
Other 8-Ks outline leadership changes such as the planned appointment of a new Executive Vice President and Chief Financial Officer, the transition of the current Chief Financial Officer into an advisory role, and the departure of the Chief Product Officer to become a Special Advisor under a consulting arrangement. Filings also cover the results of the annual meeting of stockholders, including director elections, advisory votes on executive compensation, ratification of the independent registered public accounting firm, and the outcome of stockholder proposals.
The company’s definitive proxy statement (DEF 14A) provides further detail on governance, board composition, and executive compensation, including equity awards and related valuation information. Together, these filings help investors understand Under Armour’s corporate structure, risk disclosures, and the financial and contractual terms that shape its obligations.
On Stock Titan, these documents are updated as they are posted to EDGAR, and AI-powered summaries can assist by highlighting the main points in complex filings, such as the financial implications of new debt, the scope of restructuring plans, or the specifics of executive compensation arrangements. This allows readers to quickly grasp the significance of each filing while retaining access to the full regulatory text for deeper analysis.
Gibbs David W reported acquisition or exercise transactions in this Form 4 filing.
Under Armour director David W. Gibbs received a grant of 5,133.93 shares of Class C Common Stock on April 1, 2026 as compensation, not through an open-market purchase. The award represents director fees deferred as deferred stock units under Under Armour’s Fiscal Year 2025 Non-Employee Director Compensation Plan.
Following the grant, Gibbs directly holds 173,055.67 Class C shares. He also has indirect ownership of 50,000 Class C shares through the SJG Irrevocable Trust, providing additional exposure to Under Armour’s stock separate from his direct holdings.
Whitesell Patrick reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. director Patrick Whitesell received a grant of 4,464.2900 shares of Class C Common Stock on April 1, 2026. The award represents director fees deferred as deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan and carried a stated price of $0.0000 per share. Following this grant, Whitesell directly holds 122,683.4300 shares of Class C Common Stock.
Under Armour, Inc. director Robert John Sweeney reported an acquisition of 4,910.7100 shares of Class C Common Stock. These shares were received at a stated price of $0.0000 per share as a grant or award of deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. After this award, Sweeney directly holds 180,340.6700 shares of Class C Common Stock.
Under Armour, Inc. director Dawn N. Fitzpatrick received an equity grant of 4,910.71 shares of Class C Common Stock as part of her board compensation. The shares were issued as deferred stock units under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan and carried no cash exercise price. Following this award, she directly holds a total of 180,340.67 Class C shares.
Under Armour director Carolyn Everson acquired additional equity-based compensation through deferred stock units. On April 1, 2026, she received 892.86 shares of Class C Common Stock at $0.00 per share as director fees deferred under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. Following this grant, she directly holds 108,431.14 Class C shares, reflecting routine non-employee director compensation rather than an open-market purchase or sale.
El-Erian Mohamed reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. director Mohamed El-Erian received a grant of 11,830.36 shares of Class C Common Stock as deferred stock units. The grant represents director fees deferred under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.
After this award, he holds 224,011.67 shares of Class C Common Stock and 111,650 shares of Class A Common Stock directly. This transaction reflects compensation in stock units rather than an open-market purchase or sale.
Under Armour, Inc. director Douglas E. Coltharp reported an equity award of Class C Common Stock deferred stock units. On April 1, 2026, he received 6,361.6100 Class C shares at a stated price of $0.00 per share, representing director fees deferred under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan.
After this grant, Coltharp holds 317,690.4700 Class C shares directly, along with additional direct and indirect holdings of both Class C and Class A shares through personal accounts and family trusts. The filing reflects a compensation-related acquisition rather than an open-market trade.
The Vanguard Group filed Amendment No. 12 to Schedule 13G/A reporting zero beneficial ownership of Under Armour Inc. common stock as of the amendment. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, after which certain Vanguard subsidiaries report ownership separately and Vanguard no longer is deemed to beneficially own those securities.
The form lists 0 shares beneficially owned, 0% of the class, and zero voting and dispositive power. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting 0 shares beneficially owned of Under Armour Inc. (Common Stock). The amendment explains an internal realignment on January 12, 2026 and states certain subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538. The filing lists Amount beneficially owned: 0 and Percent of class: 0%. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Under Armour, Inc. Form 144 notice reports proposed sales of multiple lots of Class A and Class C common stock that were acquired as restricted stock units. The filing lists individual lots with acquisition dates from 02/15/2015 through 02/15/2021